This building constitutes the first new factory built by GSK in the UK for nearly 40 years.

It will stand as the central focus of an important & growing GSK business area. GSK is redefining their presence in the area by involving the community based local workforce and stakeholders.

The Biopharmaceutical facility is one of several facilities proposed in the wider site master-plan. It is proposed to be a flagship building that not only fulfils a facility function, but is also architecturally engaging and seamlessly integrated within its context.

The expansion strategy will allow the building to grow in the next 5 to 10 years in the most fluid way, with minimal disruptions to functionality and with the capability of adapting to any new requirements in such a constantly changing environment as Biopharmaceutical.